Pfizer Inc. (PFE) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 8:00 AM EDT
Company Participants
Albert Bourla – Chairman of the Board & CEO
Conference Call Participants
Asad Haider – Goldman Sachs Group, Inc., Research Division
Presentation
Asad Haider
Goldman Sachs Group, Inc., Research Division
Okay. Terrific. Good morning, everyone. Welcome to our 47th Annual Global Healthcare Conference here in sunny Miami. Hopefully, it stays that way. My name is Asad Haider. I’m the Co-Head of the Healthcare Research business unit at Goldman Sachs. I’m most of the U.S. pharma analysts. I’m very pleased to open the conference with Dr. Albert Bourla, CEO of Pfizer, he kicks off our conference every year as you’ve been doing, Albert, very kindly over the past few years. Thank you very much for being with us.
We have a lot to get through, but maybe before I get into some of my specific questions, Albert, any high-level opening remarks from your end?
Albert Bourla
Chairman of the Board & CEO
I think I’m quite pleased with the way that we are executing in a strategy that I think is very solid right now. Since the changes that we did in our commercial model in the post COVID, I think the word that stands out, it is consistency in delivery, consistency in delivering. If you see 2024, 2025 and the first quarter of 2026, we beat the expectations of revenues or EPS. And in most cases, we beat on both. And that we did in despite the fact that we were reducing cost dramatically, and we were able to do to reduce cost dramatically, because we employed AI and very targeted transformational things of changing the business.
The other thing that I will point out is that we were able
